First Time Loading...

Abbvie Inc
NYSE:ABBV

Watchlist Manager
Abbvie Inc Logo
Abbvie Inc
NYSE:ABBV
Watchlist
Price: 166.245 USD 0.96% Market Closed
Updated: Apr 19, 2024

Abbvie Inc
Other Operating Expenses

Last Value
3-Years CAGR
5-Years CAGR
Quarterly
Annual
TTM
|

Abbvie Inc
Other Operating Expenses Peer Comparison

Comparables:
GILD
AMGN
VRTX
REGN
SGEN

Competitive Other Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Other Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Abbvie Inc
NYSE:ABBV
Other Operating Expenses
$179m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Other Operating Expenses
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Other Operating Expenses
$-635m
CAGR 3-Years
-50%
CAGR 5-Years
N/A
CAGR 10-Years
-12%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Other Operating Expenses
$51.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Other Operating Expenses
$2.1m
CAGR 3-Years
-80%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Seagen Inc
NASDAQ:SGEN
Other Operating Expenses
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Abbvie Inc's Other Operating Expenses?
Other Operating Expenses
179m USD

Based on the financial report for Dec 31, 2023, Abbvie Inc's Other Operating Expenses amounts to 179m USD.